SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (28934)6/24/1999 7:25:00 AM
From: Mudcat  Respond to of 32384
 
<Targretin was in advanced breast cancer trials and interim data would be available later this year>

Ligand really needs to release some early positive results from this trial prior to making the payment for Ontak. Getting the share price up prior to payment will decrease dilution.